Cancer Drugs Up To 70% Cheaper? What India’s New 30% Margin Cap Means
India has capped trade margins on non-scheduled cancer drugs at 30% of MRP, aiming to reduce prices by up to 70% and ease treatment costs.
India has capped trade margins on non-scheduled cancer drugs at 30% of MRP, aiming to reduce prices by up to 70% and ease treatment costs.
